Atlas Trials

Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

Clinical trial NCT06401642 · RECRUITING

Trial details

NCT number
NCT06401642
Sponsor
Mayo Clinic
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Migraine
Start date
2024-03-22
Primary completion
2027-03-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.